LY 245769 - CAS 127345-02-2
Catalog number:
127345-02-2
Category:
Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C25H33F3N8OS
Molecular Weight:
550.65
COA:
Inquire
Targets:
Leukotriene Receptor
Description:
LY 245769 is a leukotriene E4 (LTE4) inhibitor, and it can inhibit the oxidative degradation of LTE4 and N-acetyl-LTE4 in animal model. LY 245769, as one of the omega-trifluoro analogs of leukotrienes, will provide a new tool for interfering with the inactivation of leukotrienes in the omega-oxidation pathway.
Publictions citing BOC Sciences Products
  • >> More
Purity:
98%
Appearance:
Powder
Synonyms:
R-(R*,S*-(E,Z)))-3-(1H-tetrazol-5-yl)-alpha-(14,14,14-trifluoro-1-((2-(1H-tetrazol-5-yl)ethyl)thio)-2,4-tetradecadienyl)-3-(1H-tetrazol-5-yl)-alpha-(14,14,14-trifluoro-1-((2-(1H-tetrazol-5-yl)ethyl)thio)-2,4-tetradecadienyl)-
Solubility:
Soluble in DMSO
Storage:
-20°C Freezer
MSDS:
Inquire
Quality Standard:
In-house standard
Shelf Life:
2 month in rt, long time
Quantity:
Milligrams-Grams
InChIKey:
AISVBCUPJSXTFQ-ZSFKXVPFSA-N
InChI:
1S/C25H33F3N8OS/c26-25(27,28)16-10-8-6-4-2-1-3-5-7-9-14-21(38-17-15-22-29-33-34-30-22)23(37)19-12-11-13-20(18-19)24-31-35-36-32-24/h5,7,9,11-14,18,21,23,37H,1-4,6,8,10,15-17H2,(H,29,30,33,34)(H,31,32,35,36)/b7-5-,14-9+/t21-,23+/m1/s1
Canonical SMILES:
c1(cc(ccc1)c1nnn[nH]1)[C@H](O)[C@@H](\C=C\C=C/CCCCCCCCC(F)(F)F)SCCc1nnn[nH]1
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Leukotriene Receptor Products


CP-85958
(CAS: 134002-60-1)

This active molecular is a selective LTD4 antagonist. CP-85958 may become a clinical candidates for the treatment of asthma in the future.

Cgp-33304
(CAS: 111130-14-4)

Cgp-33304 is a dual phospholipase A2 inhibiting agent and leukotriene receptor antagonists. It may prevent hypoxia secondary to leukotriene induced bronchoconst...

CAS 107753-78-6 Zafirlukast

Zafirlukast
(CAS: 107753-78-6)

Zafirlukast is in a class of medications called leukotriene receptor antagonists (LTRAs). It works by blocking the action of certain natural substances that cau...

CAS 148291-65-0 LY 210073

LY 210073
(CAS: 148291-65-0)

LY 210073, an oxoxanthene derivative, has been found to be a LTB4 receptor antagonist that could probably be effective against inflammation and rheumatic disord...

ZM-230487
(CAS: 155944-23-3)

ZM-230487, a quinolin derivative, has been found to be a 5-lipoxygenase inhibitor as well as Leukotriene D4 receptor antagonist. It was once studied in anti-inf...

ONO-4057
(CAS: 134578-96-4)

ONO-4057 is a leukotriene B4 receptor antagonist originated by Ono Pharmaceutical. ONO-4057 is an Immunologic Factor and Immunosuppressive Agent. Clinical trial...

CAS 111130-13-3 Cgp-35949

Cgp-35949
(CAS: 111130-13-3)

Cgp-35949 is an LTD4 antagonist which has phospholipase inhibitory activity. It represents a new approach to the treatment of asthma.

LY 245769
(CAS: 127345-02-2)

LY 245769 is a leukotriene E4 (LTE4) inhibitor, and it can inhibit the oxidative degradation of LTE4 and N-acetyl-LTE4 in animal model. LY 245769, as one of the...

LY-256548
(CAS: 107889-31-6)

LY-25648 is a leukotriene B4 antagonist.

MK-571 sodium salt hydrate
(CAS: 115103-85-0)

The sodium salt hydrate of MK-571 which is an effective antagonist of CysLT1 receptor and an inhibitor of MRP1.

CAS 120443-16-5 Verlukast

Verlukast
(CAS: 120443-16-5)

This active molecular is a R-enantiomer of MK-571 which is a selective LTD4 receptor antagonist. Verlukast showed [3H]leukotriene D4 binding in guinea-pig with ...

Ono-RS-347
(CAS: 103176-67-6)

Ono-RS-347 is an SRS-A antagonist and a new leukotriene antagonists.

ICI-198615
(CAS: 104448-53-5)

ICI-198615 is a novel, potent and selective peptide leukotriene antagonist. It may be useful for the the treatment of allergic diseases.

CP-199330 Sodium
(CAS: 158102-98-8)

The sodium salt form of CP-199330 which is a chromen derivative and has been found to be a Leukotriene D4 receptor antagonist that was once studied against asth...

CAS 99107-52-5 U66858

U66858
(CAS: 99107-52-5)

U66858, also known as Bunaprolast, is a hydroquinone inhibitor of leukotriene synthesis, which inhibits LTB4 production in human whole blood.

CAS 217799-03-6 KP496

KP496
(CAS: 217799-03-6)

KP496, a novel dual antagonist of cysLT receptor and TP, is currently in clinical development as a dry powder inhaler. KP496 inhibited epithelial hypertrophy an...

LY 203647
(CAS: 122009-61-4)

LY 203647 is a a leukotriene D4 and E4 receptor antagonist with a tetrazole nucleus structure originated by Eli Lilly. No development for treatment of Ischaemic...

LY 292728
(CAS: 153034-77-6)

LY 292728, an oxoxanthene derivative, has been found to be a leukotriene B4 receptor antagonist that has once been studied as an antiasthmatic agent.

CAS 117690-79-6 LY255283

LY255283
(CAS: 117690-79-6)

This active molecular is a competitive leukotriene B4 receptor antagonist and IC50 value is about 100 nM. LY 255283 is selective for the BLT2 receptor, since IC...

CAS 712313-35-4 HAMI3379

HAMI3379
(CAS: 712313-35-4)

HAMI3379 is a cysteinyl leukotriene 2 (CysLT2) receptor antagonist. It can inhibit radioligand binding of LTD4 to CysLT2 and CysLT1 receptor cell lines with IC5...

Quick Inquiry

Verification code

Featured Items